Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$3.9MFederal grants as PI2 awards
1Patents grantedLatest Jan 17, 2023
189Papers6,198 citations
Federal awards and patents by year
AwardsPatents
2 awards · $3.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2020 | NIH | SBIR Phase II Pharmacology and human Phase 1 safety and dose escalation studies using anti-GP88 in aggressive breast cancer | $1.9M | A&G PHARMACEUTICAL, INC. |
| Sep 15, 2017 | NIH | SBIR Phase II Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies | $2.0M | A&G PHARMACEUTICAL, INC. |
2 patents as inventor
- US 11555074A&G PHARMACEUTICAL, INC.Jan 17, 2023
- US A&G PHARMACEUTICAL, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#418
Awards as PI#1,252
Patents#155
Companies
- A&G PHARMACEUTICAL, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.